183 related articles for article (PubMed ID: 37578635)
1. Intermittent Theta Burst Stimulation Attenuates Cognitive Deficits and Alzheimer's Disease-Type Pathologies via ISCA1-Mediated Mitochondrial Modulation in APP/PS1 Mice.
Zhu Y; Huang H; Chen Z; Tao Y; Liao LY; Gao SH; Wang YJ; Gao CY
Neurosci Bull; 2024 Feb; 40(2):182-200. PubMed ID: 37578635
[TBL] [Abstract][Full Text] [Related]
2. The long-term effects of intermittent theta burst stimulation on Alzheimer's disease-type pathologies in APP/PS1 mice.
Huang H; Zhu Y; Liao L; Gao S; Tao Y; Fang X; Lian Y; Gao C
Brain Res Bull; 2023 Oct; 202():110735. PubMed ID: 37586425
[TBL] [Abstract][Full Text] [Related]
3. Intermittent theta burst stimulation ameliorates cognitive impairment and hippocampal gliosis in the Streptozotocin-induced model of Alzheimer's disease.
Stanojevic J; Dragic M; Stevanovic I; Ilic T; Stojanovic I; Zeljkovic M; Ninkovic M
Behav Brain Res; 2022 Sep; 433():113984. PubMed ID: 35780960
[TBL] [Abstract][Full Text] [Related]
4. Intermittent Theta Burst Stimulation Ameliorates Cognitive Deficit and Attenuates Neuroinflammation
Stekic A; Zeljkovic M; Zaric Kontic M; Mihajlovic K; Adzic M; Stevanovic I; Ninkovic M; Grkovic I; Ilic TV; Nedeljkovic N; Dragic M
Front Aging Neurosci; 2022; 14():889983. PubMed ID: 35656538
[TBL] [Abstract][Full Text] [Related]
5. Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease.
Go J; Chang DH; Ryu YK; Park HY; Lee IB; Noh JR; Hwang DY; Kim BC; Kim KS; Lee CH
Nutr Res; 2021 Feb; 86():96-108. PubMed ID: 33551257
[TBL] [Abstract][Full Text] [Related]
6. Intermittent theta burst stimulation (iTBS) combined with working memory training to improve cognitive function in schizophrenia: study protocol for a randomized controlled trial.
Song J; Liu D; Zhang M; Wang H; Tan S
Trials; 2020 Jul; 21(1):683. PubMed ID: 32727539
[TBL] [Abstract][Full Text] [Related]
7. Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: A randomized controlled trial.
Wu X; Ji GJ; Geng Z; Wang L; Yan Y; Wu Y; Xiao G; Gao L; Wei Q; Zhou S; Wei L; Tian Y; Wang K
Brain Stimul; 2022; 15(1):35-45. PubMed ID: 34752934
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the efficacy of repetitive transcranial magnetic stimulation for patients with Alzheimer's disease.
Wang J; Huang L; Wei L; Chen W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 50(3):383-389. PubMed ID: 34402259
[TBL] [Abstract][Full Text] [Related]
9. Human ISCA1 interacts with IOP1/NARFL and functions in both cytosolic and mitochondrial iron-sulfur protein biogenesis.
Song D; Tu Z; Lee FS
J Biol Chem; 2009 Dec; 284(51):35297-307. PubMed ID: 19864422
[TBL] [Abstract][Full Text] [Related]
10. High frequency repetitive transcranial magnetic stimulation improves cognitive performance parameters in patients with Alzheimer's disease - an exploratory pilot study.
Leblhuber F; Geisler S; Ehrlich D; Steiner K; Kurz K; Fuchs D
Curr Alzheimer Res; 2022 Sep; ():. PubMed ID: 36125835
[TBL] [Abstract][Full Text] [Related]
11. Improvement of poststroke cognitive impairment by intermittent theta bursts: A double-blind randomized controlled trial.
Li W; Wen Q; Xie YH; Hu AL; Wu Q; Wang YX
Brain Behav; 2022 Jun; 12(6):e2569. PubMed ID: 35484991
[TBL] [Abstract][Full Text] [Related]
12. Transcranial magnetic stimulation improves cognition over time in Parkinson's disease.
Trung J; Hanganu A; Jobert S; Degroot C; Mejia-Constain B; Kibreab M; Bruneau MA; Lafontaine AL; Strafella A; Monchi O
Parkinsonism Relat Disord; 2019 Sep; 66():3-8. PubMed ID: 31300260
[TBL] [Abstract][Full Text] [Related]
13. ISCA1 Orchestrates ISCA2 and NFU1 in the Maturation of Human Mitochondrial [4Fe-4S] Proteins.
Suraci D; Saudino G; Nasta V; Ciofi-Baffoni S; Banci L
J Mol Biol; 2021 May; 433(10):166924. PubMed ID: 33711344
[TBL] [Abstract][Full Text] [Related]
14. Effects of a periodic intermittent theta burst stimulation in Alzheimer's disease.
Wu X; Yan Y; Hu P; Wang L; Wu Y; Wu P; Geng Z; Xiao G; Zhou S; Ji G; Qiu B; Wei L; Tian Y; Liu H; Wang K
Gen Psychiatr; 2024; 37(1):e101106. PubMed ID: 38274292
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of the efficacy of intermittent theta burst stimulation (iTBS) on cognitive enhancement.
Pabst A; Proksch S; Médé B; Comstock DC; Ross JM; Balasubramaniam R
Neurosci Biobehav Rev; 2022 Apr; 135():104587. PubMed ID: 35202646
[TBL] [Abstract][Full Text] [Related]
16. Danggui Buxue decoction ameliorates mitochondrial biogenesis and cognitive deficits through upregulating histone H4 lysine 12 acetylation in APP/PS1 mice.
Chai GS; Gong J; Wu JJ; Ma RK; Zhu J; Jia DD; Zhang YQ; Zhai XR; Sun HX; Nie YJ; Zhao P; Xu YL; Yu HT
J Ethnopharmacol; 2023 Sep; 313():116554. PubMed ID: 37137453
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Intermittent Theta-Burst Stimulation and Transcranial Direct Current Stimulation in Treatment of Post-Stroke Cognitive Impairment.
Chu M; Zhang Y; Chen J; Chen W; Hong Z; Zhang Y; Yu H; Zhang F; Ye X; Li J; Yang Y
J Integr Neurosci; 2022 Jul; 21(5):130. PubMed ID: 36137957
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
[TBL] [Abstract][Full Text] [Related]
19. The effect of intermittent theta burst stimulation for cognitive dysfunction: a meta-analysis.
Zheng B; Chen J; Cao M; Zhang Y; Chen S; Yu H; Liang K
Brain Inj; 2024 Jul; 38(9):675-686. PubMed ID: 38651344
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
